Fibroid Tumor
0.310
AlteredExpression
disease
BEFREE
Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts.
15972578
2005
Fibroid Tumor
0.310
Biomarker
disease
CTD_human
Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts.
15972578
2005
Fibroid Tumor
0.310
AlteredExpression
disease
LHGDN
Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts.
15972578
2005
Uterine Fibroids
0.310
AlteredExpression
group
BEFREE
Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts.
15972578
2005
Uterine Fibroids
0.310
Biomarker
group
CTD_human
Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts.
15972578
2005
Adenoid Cystic Carcinoma
0.300
Biomarker
disease
CTD_human
Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.
16762588
2006
Salivary Gland Neoplasms
0.300
Biomarker
group
CTD_human
Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.
16762588
2006
Malignant neoplasm of salivary gland
0.300
Biomarker
disease
CTD_human
Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.
16762588
2006
Bone Density
0.100
GeneticVariation
phenotype
GWASCAT
Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects.
29304378
2018
Arthritis, Gouty
0.100
GeneticVariation
disease
GWASCAT
Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences.
22179738
2012
×
CUI:
C0018099
Disease:
Gout
Gout
0.100
GeneticVariation
disease
GWASCAT
Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences.
22179738
2012
Malignant Neoplasms
0.030
Biomarker
group
BEFREE
Limited investigations revealed a possible role of WNT5B in malignancies , such as triple-negative breast cancer and oral squamous cell carcinoma.
31666682
2020
Squamous cell carcinoma
0.030
Biomarker
disease
BEFREE
Limited investigations revealed a possible role of WNT5B in malignancies, such as triple-negative breast cancer and oral squamous cell carcinoma .
31666682
2020
Malignant Neoplasms
0.030
Biomarker
group
BEFREE
These results suggest that Wnt5b -associated exosomes promote cancer cell migration and proliferation in a paracrine manner.
27762090
2017
Squamous cell carcinoma
0.030
AlteredExpression
disease
BEFREE
Interestingly, the high level of WNT5B protein in serum was associated with lymph node metastasis in OSCC patients.
27593938
2017
Malignant Neoplasms
0.030
Biomarker
group
BEFREE
WNT5B is a member of the WNT family that has been reported to be overexpressed in a variety of cancer cell lines and tissues, including colorectal cancer (CRC).
27121420
2016
Squamous cell carcinoma
0.030
Biomarker
disease
BEFREE
Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA.
24220306
2014
Diabetes Mellitus, Non-Insulin-Dependent
0.030
AlteredExpression
disease
BEFREE
Down-regulation of Wnt5b could therefore contribute to decreased adipogenesis observed in T2DM diabetic subjects.
19577541
2009
Diabetes Mellitus, Non-Insulin-Dependent
0.030
GeneticVariation
disease
BEFREE
Two thousand seven hundred and one Caucasian middle-aged men from the prospective Northwick Park Heart Study II (NPHSII) of whom 153 developed T2D over 15 years and 1268 Caucasian middle-aged patients with T2D (60% male) were genotyped using a TaqMan assay for the IVS3C>G variant (rs2270031 ) in the WNT5B gene.
18555673
2009
Diabetes Mellitus, Non-Insulin-Dependent
0.030
GeneticVariation
disease
BEFREE
As a result, one SNP locus in the WNT5B gene was strongly associated with type 2 diabetes ( chi 2=15.6; P=.00008; odds ratio=1.74; 95% confidence interval 1.32-2.29).
15386214
2004
Secondary malignant neoplasm of lymph node
0.020
AlteredExpression
disease
BEFREE
Here, we initially determine that WNT5B is highly expressed in LAD and is positively correlated with lymph node metastasis and TNM stage.
31666682
2020
Malignant neoplasm of breast
0.020
AlteredExpression
disease
BEFREE
IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer .
29847788
2018
Breast Carcinoma
0.020
AlteredExpression
disease
BEFREE
IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer .
29847788
2018
Neoplasms
0.020
AlteredExpression
group
BEFREE
Knockdown of WNT5B expression in OSCC sublines did not affect tumour growth but impaired lymph node metastasis and tumour lymphangiogenesis of orthotopic transplantation.
27593938
2017
Secondary malignant neoplasm of lymph node
0.020
AlteredExpression
disease
BEFREE
Knockdown of WNT5B expression in OSCC sublines did not affect tumour growth but impaired lymph node metastasis and tumour lymphangiogenesis of orthotopic transplantation.
27593938
2017